Agenus (AGEN) Competitors

Agenus (NASDAQ:AGEN) and Codexis (NASDAQ:CDXS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, community ranking, dividends and analyst recommendations.

Do insiders & institutionals have more ownership in AGEN or CDXS?

61.5% of Agenus shares are held by institutional investors. Comparatively, 78.5% of Codexis shares are held by institutional investors. 4.6% of Agenus shares are held by insiders. Comparatively, 2.1% of Codexis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts prefer AGEN or CDXS?

Agenus presently has a consensus target price of $8.75, suggesting a potential upside of 417.75%. Codexis has a consensus target price of $8.33, suggesting a potential upside of 270.37%. Given Agenus' higher possible upside, equities research analysts clearly believe Agenus is more favorable than Codexis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agenus	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Codexis	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Is AGEN or CDXS more profitable?

Codexis has a net margin of -96.35% compared to Agenus' net margin of -145.89%. Agenus' return on equity of 0.00% beat Codexis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agenus	-145.89%	N/A	-85.68%
Codexis	-96.35%	-71.56%	-38.00%

Does the MarketBeat Community believe in AGEN or CDXS?

Agenus received 116 more outperform votes than Codexis when rated by MarketBeat users. Likewise, 68.78% of users gave Agenus an outperform vote while only 61.47% of users gave Codexis an outperform vote.

Company	Underperform	Outperform
Agenus	Outperform Votes 467 68.78%	Underperform Votes 212 31.22%
Codexis	Outperform Votes 351 61.47%	Underperform Votes 220 38.53%

Which has higher earnings and valuation, AGEN or CDXS?

Codexis has lower revenue, but higher earnings than Agenus. Codexis is trading at a lower price-to-earnings ratio than Agenus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agenus	$103.46M	0.41	-$245.76M	-$10.68	-0.16
Codexis	$59.35M	3.14	-$76.24M	-$0.90	-2.50

Does the media favor AGEN or CDXS?

In the previous week, Codexis had 5 more articles in the media than Agenus. MarketBeat recorded 7 mentions for Codexis and 2 mentions for Agenus. Agenus' average media sentiment score of 0.94 beat Codexis' score of 0.80 indicating that Agenus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agenus	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Codexis	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, AGEN or CDXS?

Agenus has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Codexis has a beta of 2.35, meaning that its share price is 135% more volatile than the S&P 500.

Summary

Codexis beats Agenus on 10 of the 18 factors compared between the two stocks.